Healthcare -
Biotechnology - NASDAQ - US
$ 33.61
3 %
$ 4.01 B
Market Cap
-11.67
P/E
RNA - SHORT-TERM DEBT
Short-term Debt RNA - Avidity Biosciences, Inc.
14.8 M
LAST VALUE
104.78%
2 YEAR CAGR
40.13%
5 YEAR CAGR
0.00%
10 YEAR CAGR